nodes	percent_of_prediction	percent_of_DWPC	metapath
Sunitinib—DAPK1—brain cancer	0.295	0.525	CbGaD
Sunitinib—ALK—brain cancer	0.148	0.263	CbGaD
Sunitinib—PDGFRA—brain cancer	0.119	0.212	CbGaD
Sunitinib—ABCC2—Carboplatin—brain cancer	0.00831	0.171	CbGbCtD
Sunitinib—ABCG2—Carboplatin—brain cancer	0.00751	0.155	CbGbCtD
Sunitinib—ABCC2—Etoposide—brain cancer	0.00698	0.144	CbGbCtD
Sunitinib—CYP3A4—Temozolomide—brain cancer	0.00663	0.137	CbGbCtD
Sunitinib—ABCG2—Etoposide—brain cancer	0.00631	0.13	CbGbCtD
Sunitinib—CYP3A4—Lomustine—brain cancer	0.00564	0.116	CbGbCtD
Sunitinib—CYP3A5—Etoposide—brain cancer	0.00349	0.072	CbGbCtD
Sunitinib—ABCB1—Etoposide—brain cancer	0.00227	0.0469	CbGbCtD
Sunitinib—Procainamide—DNMT1—brain cancer	0.00173	1	CrCbGaD
Sunitinib—CYP3A4—Etoposide—brain cancer	0.00136	0.0281	CbGbCtD
Sunitinib—STK24—Teniposide—Etoposide—brain cancer	0.0013	0.532	CbGdCrCtD
Sunitinib—PLK4—Teniposide—Etoposide—brain cancer	0.000415	0.169	CbGdCrCtD
Sunitinib—CHEK2—Podofilox—Etoposide—brain cancer	0.000366	0.149	CbGdCrCtD
Sunitinib—CHEK2—Teniposide—Etoposide—brain cancer	0.000366	0.149	CbGdCrCtD
Sunitinib—Pancytopenia—Carmustine—brain cancer	0.000189	0.00199	CcSEcCtD
Sunitinib—Arthralgia—Procarbazine—brain cancer	0.000189	0.00199	CcSEcCtD
Sunitinib—Myalgia—Procarbazine—brain cancer	0.000189	0.00199	CcSEcCtD
Sunitinib—Neutropenia—Carmustine—brain cancer	0.000186	0.00196	CcSEcCtD
Sunitinib—Bronchitis—Temozolomide—brain cancer	0.000185	0.00195	CcSEcCtD
Sunitinib—Dry mouth—Procarbazine—brain cancer	0.000185	0.00195	CcSEcCtD
Sunitinib—Pancytopenia—Temozolomide—brain cancer	0.000183	0.00193	CcSEcCtD
Sunitinib—Cardiac failure—Etoposide—brain cancer	0.000183	0.00192	CcSEcCtD
Sunitinib—Vomiting—Lomustine—brain cancer	0.000181	0.00191	CcSEcCtD
Sunitinib—Oedema—Procarbazine—brain cancer	0.000181	0.00191	CcSEcCtD
Sunitinib—Neutropenia—Temozolomide—brain cancer	0.00018	0.0019	CcSEcCtD
Sunitinib—Infection—Procarbazine—brain cancer	0.00018	0.0019	CcSEcCtD
Sunitinib—Hyperglycaemia—Carmustine—brain cancer	0.00018	0.00189	CcSEcCtD
Sunitinib—Angiopathy—Hydroxyurea—brain cancer	0.000179	0.00189	CcSEcCtD
Sunitinib—Upper respiratory tract infection—Temozolomide—brain cancer	0.000179	0.00189	CcSEcCtD
Sunitinib—Pneumonia—Carmustine—brain cancer	0.000179	0.00188	CcSEcCtD
Sunitinib—Shock—Procarbazine—brain cancer	0.000178	0.00188	CcSEcCtD
Sunitinib—Thrombocytopenia—Procarbazine—brain cancer	0.000177	0.00187	CcSEcCtD
Sunitinib—Depression—Carmustine—brain cancer	0.000177	0.00187	CcSEcCtD
Sunitinib—Chills—Hydroxyurea—brain cancer	0.000177	0.00186	CcSEcCtD
Sunitinib—Renal failure—Carmustine—brain cancer	0.000175	0.00184	CcSEcCtD
Sunitinib—Alopecia—Hydroxyurea—brain cancer	0.000174	0.00184	CcSEcCtD
Sunitinib—Weight decreased—Temozolomide—brain cancer	0.000174	0.00184	CcSEcCtD
Sunitinib—Neuropathy peripheral—Carmustine—brain cancer	0.000174	0.00183	CcSEcCtD
Sunitinib—Hyperglycaemia—Temozolomide—brain cancer	0.000174	0.00183	CcSEcCtD
Sunitinib—Stomatitis—Carmustine—brain cancer	0.000173	0.00182	CcSEcCtD
Sunitinib—Urinary tract infection—Carmustine—brain cancer	0.000173	0.00182	CcSEcCtD
Sunitinib—Pneumonia—Temozolomide—brain cancer	0.000173	0.00182	CcSEcCtD
Sunitinib—Anorexia—Procarbazine—brain cancer	0.000173	0.00182	CcSEcCtD
Sunitinib—Erythema—Hydroxyurea—brain cancer	0.000172	0.00181	CcSEcCtD
Sunitinib—Infestation NOS—Temozolomide—brain cancer	0.000172	0.00181	CcSEcCtD
Sunitinib—Infestation—Temozolomide—brain cancer	0.000172	0.00181	CcSEcCtD
Sunitinib—Depression—Temozolomide—brain cancer	0.000171	0.0018	CcSEcCtD
Sunitinib—Stevens-Johnson syndrome—Temozolomide—brain cancer	0.00017	0.00179	CcSEcCtD
Sunitinib—Nausea—Lomustine—brain cancer	0.00017	0.00179	CcSEcCtD
Sunitinib—Neuropathy peripheral—Temozolomide—brain cancer	0.000168	0.00177	CcSEcCtD
Sunitinib—Stomatitis—Temozolomide—brain cancer	0.000167	0.00176	CcSEcCtD
Sunitinib—Urinary tract infection—Temozolomide—brain cancer	0.000167	0.00176	CcSEcCtD
Sunitinib—Musculoskeletal discomfort—Procarbazine—brain cancer	0.000165	0.00174	CcSEcCtD
Sunitinib—Insomnia—Procarbazine—brain cancer	0.000164	0.00173	CcSEcCtD
Sunitinib—Paraesthesia—Procarbazine—brain cancer	0.000163	0.00171	CcSEcCtD
Sunitinib—Hepatobiliary disease—Temozolomide—brain cancer	0.000162	0.00171	CcSEcCtD
Sunitinib—Toxic epidermal necrolysis—Etoposide—brain cancer	0.000161	0.00169	CcSEcCtD
Sunitinib—Haemoglobin—Carmustine—brain cancer	0.00016	0.00169	CcSEcCtD
Sunitinib—Haemorrhage—Carmustine—brain cancer	0.00016	0.00168	CcSEcCtD
Sunitinib—Anaemia—Hydroxyurea—brain cancer	0.000159	0.00167	CcSEcCtD
Sunitinib—Hypoaesthesia—Carmustine—brain cancer	0.000159	0.00167	CcSEcCtD
Sunitinib—Decreased appetite—Procarbazine—brain cancer	0.000158	0.00166	CcSEcCtD
Sunitinib—Alanine aminotransferase increased—Etoposide—brain cancer	0.000157	0.00166	CcSEcCtD
Sunitinib—Oedema peripheral—Carmustine—brain cancer	0.000157	0.00166	CcSEcCtD
Sunitinib—Connective tissue disorder—Carmustine—brain cancer	0.000157	0.00165	CcSEcCtD
Sunitinib—Fatigue—Procarbazine—brain cancer	0.000156	0.00164	CcSEcCtD
Sunitinib—Haemoglobin—Temozolomide—brain cancer	0.000155	0.00163	CcSEcCtD
Sunitinib—Pain—Procarbazine—brain cancer	0.000155	0.00163	CcSEcCtD
Sunitinib—Constipation—Procarbazine—brain cancer	0.000155	0.00163	CcSEcCtD
Sunitinib—Haemorrhage—Temozolomide—brain cancer	0.000154	0.00162	CcSEcCtD
Sunitinib—Hepatitis—Temozolomide—brain cancer	0.000154	0.00162	CcSEcCtD
Sunitinib—Dysphagia—Etoposide—brain cancer	0.000154	0.00162	CcSEcCtD
Sunitinib—Leukopenia—Hydroxyurea—brain cancer	0.000154	0.00162	CcSEcCtD
Sunitinib—Hypoaesthesia—Temozolomide—brain cancer	0.000153	0.00162	CcSEcCtD
Sunitinib—Urinary tract disorder—Temozolomide—brain cancer	0.000152	0.0016	CcSEcCtD
Sunitinib—Oedema peripheral—Temozolomide—brain cancer	0.000152	0.0016	CcSEcCtD
Sunitinib—Connective tissue disorder—Temozolomide—brain cancer	0.000152	0.0016	CcSEcCtD
Sunitinib—Urethral disorder—Temozolomide—brain cancer	0.000151	0.00159	CcSEcCtD
Sunitinib—Eye disorder—Carmustine—brain cancer	0.000149	0.00157	CcSEcCtD
Sunitinib—Convulsion—Hydroxyurea—brain cancer	0.000149	0.00157	CcSEcCtD
Sunitinib—Gastrointestinal pain—Procarbazine—brain cancer	0.000148	0.00156	CcSEcCtD
Sunitinib—Flushing—Carmustine—brain cancer	0.000148	0.00156	CcSEcCtD
Sunitinib—Pancytopenia—Etoposide—brain cancer	0.000146	0.00154	CcSEcCtD
Sunitinib—Erythema multiforme—Temozolomide—brain cancer	0.000146	0.00154	CcSEcCtD
Sunitinib—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—brain cancer	0.000145	0.00153	CcSEcCtD
Sunitinib—Neutropenia—Etoposide—brain cancer	0.000144	0.00152	CcSEcCtD
Sunitinib—Eye disorder—Temozolomide—brain cancer	0.000144	0.00152	CcSEcCtD
Sunitinib—Abdominal pain—Procarbazine—brain cancer	0.000143	0.00151	CcSEcCtD
Sunitinib—Body temperature increased—Procarbazine—brain cancer	0.000143	0.00151	CcSEcCtD
Sunitinib—Cardiac disorder—Temozolomide—brain cancer	0.000143	0.00151	CcSEcCtD
Sunitinib—Flushing—Temozolomide—brain cancer	0.000143	0.00151	CcSEcCtD
Sunitinib—Arrhythmia—Carmustine—brain cancer	0.000143	0.0015	CcSEcCtD
Sunitinib—Alopecia—Carmustine—brain cancer	0.000141	0.00148	CcSEcCtD
Sunitinib—Oedema—Hydroxyurea—brain cancer	0.00014	0.00148	CcSEcCtD
Sunitinib—Angiopathy—Temozolomide—brain cancer	0.00014	0.00147	CcSEcCtD
Sunitinib—Mental disorder—Carmustine—brain cancer	0.00014	0.00147	CcSEcCtD
Sunitinib—Infection—Hydroxyurea—brain cancer	0.000139	0.00147	CcSEcCtD
Sunitinib—Immune system disorder—Temozolomide—brain cancer	0.000139	0.00147	CcSEcCtD
Sunitinib—Mediastinal disorder—Temozolomide—brain cancer	0.000139	0.00146	CcSEcCtD
Sunitinib—Erythema—Carmustine—brain cancer	0.000139	0.00146	CcSEcCtD
Sunitinib—Malnutrition—Carmustine—brain cancer	0.000139	0.00146	CcSEcCtD
Sunitinib—Chills—Temozolomide—brain cancer	0.000138	0.00146	CcSEcCtD
Sunitinib—Pneumonia—Etoposide—brain cancer	0.000138	0.00146	CcSEcCtD
Sunitinib—Nervous system disorder—Hydroxyurea—brain cancer	0.000138	0.00145	CcSEcCtD
Sunitinib—Infestation NOS—Etoposide—brain cancer	0.000137	0.00145	CcSEcCtD
Sunitinib—Infestation—Etoposide—brain cancer	0.000137	0.00145	CcSEcCtD
Sunitinib—Thrombocytopenia—Hydroxyurea—brain cancer	0.000137	0.00145	CcSEcCtD
Sunitinib—Stevens-Johnson syndrome—Etoposide—brain cancer	0.000136	0.00143	CcSEcCtD
Sunitinib—Alopecia—Temozolomide—brain cancer	0.000136	0.00143	CcSEcCtD
Sunitinib—Skin disorder—Hydroxyurea—brain cancer	0.000136	0.00143	CcSEcCtD
Sunitinib—Acute coronary syndrome—Etoposide—brain cancer	0.000136	0.00143	CcSEcCtD
Sunitinib—Renal failure—Etoposide—brain cancer	0.000135	0.00142	CcSEcCtD
Sunitinib—Mental disorder—Temozolomide—brain cancer	0.000135	0.00142	CcSEcCtD
Sunitinib—Neuropathy peripheral—Etoposide—brain cancer	0.000135	0.00142	CcSEcCtD
Sunitinib—Back pain—Carmustine—brain cancer	0.000134	0.00141	CcSEcCtD
Sunitinib—Erythema—Temozolomide—brain cancer	0.000134	0.00141	CcSEcCtD
Sunitinib—Malnutrition—Temozolomide—brain cancer	0.000134	0.00141	CcSEcCtD
Sunitinib—Stomatitis—Etoposide—brain cancer	0.000134	0.00141	CcSEcCtD
Sunitinib—Anorexia—Hydroxyurea—brain cancer	0.000134	0.00141	CcSEcCtD
Sunitinib—Hypersensitivity—Procarbazine—brain cancer	0.000134	0.00141	CcSEcCtD
Sunitinib—Dysgeusia—Temozolomide—brain cancer	0.000131	0.00138	CcSEcCtD
Sunitinib—Asthenia—Procarbazine—brain cancer	0.00013	0.00137	CcSEcCtD
Sunitinib—Hepatobiliary disease—Etoposide—brain cancer	0.00013	0.00137	CcSEcCtD
Sunitinib—Back pain—Temozolomide—brain cancer	0.00013	0.00137	CcSEcCtD
Sunitinib—Anaemia—Carmustine—brain cancer	0.000128	0.00135	CcSEcCtD
Sunitinib—Pruritus—Procarbazine—brain cancer	0.000128	0.00135	CcSEcCtD
Sunitinib—Dyspnoea—Hydroxyurea—brain cancer	0.000125	0.00132	CcSEcCtD
Sunitinib—Leukopenia—Carmustine—brain cancer	0.000124	0.00131	CcSEcCtD
Sunitinib—Anaemia—Temozolomide—brain cancer	0.000124	0.00131	CcSEcCtD
Sunitinib—Diarrhoea—Procarbazine—brain cancer	0.000124	0.00131	CcSEcCtD
Sunitinib—Dyspepsia—Hydroxyurea—brain cancer	0.000123	0.0013	CcSEcCtD
Sunitinib—Hypoaesthesia—Etoposide—brain cancer	0.000123	0.00129	CcSEcCtD
Sunitinib—Angioedema—Temozolomide—brain cancer	0.000123	0.00129	CcSEcCtD
Sunitinib—Decreased appetite—Hydroxyurea—brain cancer	0.000122	0.00128	CcSEcCtD
Sunitinib—Urinary tract disorder—Etoposide—brain cancer	0.000122	0.00128	CcSEcCtD
Sunitinib—Gastrointestinal disorder—Hydroxyurea—brain cancer	0.000121	0.00127	CcSEcCtD
Sunitinib—Urethral disorder—Etoposide—brain cancer	0.000121	0.00127	CcSEcCtD
Sunitinib—Fatigue—Hydroxyurea—brain cancer	0.000121	0.00127	CcSEcCtD
Sunitinib—Convulsion—Carmustine—brain cancer	0.00012	0.00127	CcSEcCtD
Sunitinib—Leukopenia—Temozolomide—brain cancer	0.00012	0.00127	CcSEcCtD
Sunitinib—Hypertension—Carmustine—brain cancer	0.00012	0.00126	CcSEcCtD
Sunitinib—Constipation—Hydroxyurea—brain cancer	0.00012	0.00126	CcSEcCtD
Sunitinib—Pain—Hydroxyurea—brain cancer	0.00012	0.00126	CcSEcCtD
Sunitinib—Dizziness—Procarbazine—brain cancer	0.00012	0.00126	CcSEcCtD
Sunitinib—Chest pain—Carmustine—brain cancer	0.000118	0.00125	CcSEcCtD
Sunitinib—Myalgia—Carmustine—brain cancer	0.000118	0.00125	CcSEcCtD
Sunitinib—Cough—Temozolomide—brain cancer	0.000117	0.00123	CcSEcCtD
Sunitinib—Erythema multiforme—Etoposide—brain cancer	0.000117	0.00123	CcSEcCtD
Sunitinib—Convulsion—Temozolomide—brain cancer	0.000116	0.00122	CcSEcCtD
Sunitinib—Hypertension—Temozolomide—brain cancer	0.000116	0.00122	CcSEcCtD
Sunitinib—Eye disorder—Etoposide—brain cancer	0.000115	0.00121	CcSEcCtD
Sunitinib—Vomiting—Procarbazine—brain cancer	0.000115	0.00121	CcSEcCtD
Sunitinib—Cardiac disorder—Etoposide—brain cancer	0.000115	0.00121	CcSEcCtD
Sunitinib—Flushing—Etoposide—brain cancer	0.000115	0.00121	CcSEcCtD
Sunitinib—Arthralgia—Temozolomide—brain cancer	0.000114	0.0012	CcSEcCtD
Sunitinib—Myalgia—Temozolomide—brain cancer	0.000114	0.0012	CcSEcCtD
Sunitinib—Rash—Procarbazine—brain cancer	0.000114	0.0012	CcSEcCtD
Sunitinib—Dermatitis—Procarbazine—brain cancer	0.000114	0.0012	CcSEcCtD
Sunitinib—Headache—Procarbazine—brain cancer	0.000114	0.0012	CcSEcCtD
Sunitinib—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—brain cancer	0.000113	0.0012	CcSEcCtD
Sunitinib—Oedema—Carmustine—brain cancer	0.000113	0.00119	CcSEcCtD
Sunitinib—Infection—Carmustine—brain cancer	0.000113	0.00119	CcSEcCtD
Sunitinib—Angiopathy—Etoposide—brain cancer	0.000112	0.00118	CcSEcCtD
Sunitinib—Dry mouth—Temozolomide—brain cancer	0.000112	0.00118	CcSEcCtD
Sunitinib—Immune system disorder—Etoposide—brain cancer	0.000111	0.00117	CcSEcCtD
Sunitinib—Mediastinal disorder—Etoposide—brain cancer	0.000111	0.00117	CcSEcCtD
Sunitinib—Thrombocytopenia—Carmustine—brain cancer	0.000111	0.00117	CcSEcCtD
Sunitinib—Body temperature increased—Hydroxyurea—brain cancer	0.000111	0.00117	CcSEcCtD
Sunitinib—Chills—Etoposide—brain cancer	0.000111	0.00117	CcSEcCtD
Sunitinib—Oedema—Temozolomide—brain cancer	0.00011	0.00115	CcSEcCtD
Sunitinib—Alopecia—Etoposide—brain cancer	0.000109	0.00115	CcSEcCtD
Sunitinib—Infection—Temozolomide—brain cancer	0.000109	0.00115	CcSEcCtD
Sunitinib—Anorexia—Carmustine—brain cancer	0.000108	0.00114	CcSEcCtD
Sunitinib—Nausea—Procarbazine—brain cancer	0.000108	0.00113	CcSEcCtD
Sunitinib—Nervous system disorder—Temozolomide—brain cancer	0.000107	0.00113	CcSEcCtD
Sunitinib—Thrombocytopenia—Temozolomide—brain cancer	0.000107	0.00113	CcSEcCtD
Sunitinib—Skin disorder—Temozolomide—brain cancer	0.000106	0.00112	CcSEcCtD
Sunitinib—Dysgeusia—Etoposide—brain cancer	0.000105	0.00111	CcSEcCtD
Sunitinib—Anorexia—Temozolomide—brain cancer	0.000104	0.0011	CcSEcCtD
Sunitinib—Back pain—Etoposide—brain cancer	0.000104	0.00109	CcSEcCtD
Sunitinib—Hypersensitivity—Hydroxyurea—brain cancer	0.000103	0.00109	CcSEcCtD
Sunitinib—Musculoskeletal discomfort—Carmustine—brain cancer	0.000103	0.00109	CcSEcCtD
Sunitinib—Muscle spasms—Etoposide—brain cancer	0.000103	0.00109	CcSEcCtD
Sunitinib—Insomnia—Carmustine—brain cancer	0.000103	0.00108	CcSEcCtD
Sunitinib—Paraesthesia—Carmustine—brain cancer	0.000102	0.00107	CcSEcCtD
Sunitinib—Dyspnoea—Carmustine—brain cancer	0.000101	0.00106	CcSEcCtD
Sunitinib—Asthenia—Hydroxyurea—brain cancer	0.000101	0.00106	CcSEcCtD
Sunitinib—Musculoskeletal discomfort—Temozolomide—brain cancer	9.98e-05	0.00105	CcSEcCtD
Sunitinib—Anaemia—Etoposide—brain cancer	9.93e-05	0.00105	CcSEcCtD
Sunitinib—Insomnia—Temozolomide—brain cancer	9.91e-05	0.00104	CcSEcCtD
Sunitinib—Decreased appetite—Carmustine—brain cancer	9.86e-05	0.00104	CcSEcCtD
Sunitinib—Paraesthesia—Temozolomide—brain cancer	9.84e-05	0.00104	CcSEcCtD
Sunitinib—Gastrointestinal disorder—Carmustine—brain cancer	9.79e-05	0.00103	CcSEcCtD
Sunitinib—Dyspnoea—Temozolomide—brain cancer	9.77e-05	0.00103	CcSEcCtD
Sunitinib—Pain—Carmustine—brain cancer	9.69e-05	0.00102	CcSEcCtD
Sunitinib—Constipation—Carmustine—brain cancer	9.69e-05	0.00102	CcSEcCtD
Sunitinib—Dyspepsia—Temozolomide—brain cancer	9.64e-05	0.00102	CcSEcCtD
Sunitinib—Leukopenia—Etoposide—brain cancer	9.62e-05	0.00101	CcSEcCtD
Sunitinib—Diarrhoea—Hydroxyurea—brain cancer	9.6e-05	0.00101	CcSEcCtD
Sunitinib—Decreased appetite—Temozolomide—brain cancer	9.52e-05	0.001	CcSEcCtD
Sunitinib—Gastrointestinal disorder—Temozolomide—brain cancer	9.46e-05	0.000996	CcSEcCtD
Sunitinib—Fatigue—Temozolomide—brain cancer	9.45e-05	0.000995	CcSEcCtD
Sunitinib—Cough—Etoposide—brain cancer	9.37e-05	0.000987	CcSEcCtD
Sunitinib—Pain—Temozolomide—brain cancer	9.37e-05	0.000986	CcSEcCtD
Sunitinib—Constipation—Temozolomide—brain cancer	9.37e-05	0.000986	CcSEcCtD
Sunitinib—Convulsion—Etoposide—brain cancer	9.31e-05	0.00098	CcSEcCtD
Sunitinib—Hypertension—Etoposide—brain cancer	9.27e-05	0.000977	CcSEcCtD
Sunitinib—Dizziness—Hydroxyurea—brain cancer	9.27e-05	0.000976	CcSEcCtD
Sunitinib—Gastrointestinal pain—Carmustine—brain cancer	9.27e-05	0.000976	CcSEcCtD
Sunitinib—Chest pain—Etoposide—brain cancer	9.15e-05	0.000963	CcSEcCtD
Sunitinib—Unspecified disorder of skin and subcutaneous tissue—Etoposide—brain cancer	9.08e-05	0.000956	CcSEcCtD
Sunitinib—Abdominal pain—Carmustine—brain cancer	8.96e-05	0.000944	CcSEcCtD
Sunitinib—Body temperature increased—Carmustine—brain cancer	8.96e-05	0.000944	CcSEcCtD
Sunitinib—Gastrointestinal pain—Temozolomide—brain cancer	8.96e-05	0.000943	CcSEcCtD
Sunitinib—Vomiting—Hydroxyurea—brain cancer	8.92e-05	0.000939	CcSEcCtD
Sunitinib—Rash—Hydroxyurea—brain cancer	8.84e-05	0.000931	CcSEcCtD
Sunitinib—Dermatitis—Hydroxyurea—brain cancer	8.83e-05	0.00093	CcSEcCtD
Sunitinib—Headache—Hydroxyurea—brain cancer	8.79e-05	0.000925	CcSEcCtD
Sunitinib—CLK1—cerebellum—brain cancer	8.71e-05	0.000685	CbGeAlD
Sunitinib—Infection—Etoposide—brain cancer	8.71e-05	0.000917	CcSEcCtD
Sunitinib—STK16—brain—brain cancer	8.71e-05	0.000685	CbGeAlD
Sunitinib—MAP3K2—head—brain cancer	8.7e-05	0.000685	CbGeAlD
Sunitinib—LRRK2—central nervous system—brain cancer	8.67e-05	0.000682	CbGeAlD
Sunitinib—JAK2—spinal cord—brain cancer	8.66e-05	0.000682	CbGeAlD
Sunitinib—Body temperature increased—Temozolomide—brain cancer	8.66e-05	0.000912	CcSEcCtD
Sunitinib—Abdominal pain—Temozolomide—brain cancer	8.66e-05	0.000912	CcSEcCtD
Sunitinib—HIPK3—brain—brain cancer	8.66e-05	0.000681	CbGeAlD
Sunitinib—HIPK2—brain—brain cancer	8.66e-05	0.000681	CbGeAlD
Sunitinib—ALK—brain—brain cancer	8.66e-05	0.000681	CbGeAlD
Sunitinib—TYRO3—brain—brain cancer	8.66e-05	0.000681	CbGeAlD
Sunitinib—YES1—medulla oblongata—brain cancer	8.65e-05	0.000681	CbGeAlD
Sunitinib—KIT—telencephalon—brain cancer	8.63e-05	0.000679	CbGeAlD
Sunitinib—TBK1—endocrine gland—brain cancer	8.63e-05	0.000679	CbGeAlD
Sunitinib—Thrombocytopenia—Etoposide—brain cancer	8.58e-05	0.000904	CcSEcCtD
Sunitinib—TYK2—endocrine gland—brain cancer	8.57e-05	0.000675	CbGeAlD
Sunitinib—TNK1—brain—brain cancer	8.57e-05	0.000674	CbGeAlD
Sunitinib—RIOK2—brain—brain cancer	8.57e-05	0.000674	CbGeAlD
Sunitinib—MAP4K5—midbrain—brain cancer	8.56e-05	0.000674	CbGeAlD
Sunitinib—MAP3K3—midbrain—brain cancer	8.56e-05	0.000674	CbGeAlD
Sunitinib—CAMK2G—cerebellum—brain cancer	8.55e-05	0.000673	CbGeAlD
Sunitinib—BMP2K—cerebellum—brain cancer	8.55e-05	0.000673	CbGeAlD
Sunitinib—FYN—spinal cord—brain cancer	8.55e-05	0.000672	CbGeAlD
Sunitinib—PRKAA1—central nervous system—brain cancer	8.54e-05	0.000672	CbGeAlD
Sunitinib—TAOK3—medulla oblongata—brain cancer	8.54e-05	0.000672	CbGeAlD
Sunitinib—TBK1—head—brain cancer	8.52e-05	0.000671	CbGeAlD
Sunitinib—Skin disorder—Etoposide—brain cancer	8.52e-05	0.000897	CcSEcCtD
Sunitinib—MAP3K19—brain—brain cancer	8.48e-05	0.000668	CbGeAlD
Sunitinib—MAP4K1—brain—brain cancer	8.48e-05	0.000668	CbGeAlD
Sunitinib—LRRK2—cerebellum—brain cancer	8.47e-05	0.000667	CbGeAlD
Sunitinib—TYK2—head—brain cancer	8.46e-05	0.000666	CbGeAlD
Sunitinib—PTK2B—central nervous system—brain cancer	8.45e-05	0.000665	CbGeAlD
Sunitinib—PDGFRB—telencephalon—brain cancer	8.43e-05	0.000663	CbGeAlD
Sunitinib—Anorexia—Etoposide—brain cancer	8.36e-05	0.00088	CcSEcCtD
Sunitinib—Hypersensitivity—Carmustine—brain cancer	8.35e-05	0.000879	CcSEcCtD
Sunitinib—MAP4K5—spinal cord—brain cancer	8.35e-05	0.000657	CbGeAlD
Sunitinib—MAP3K3—spinal cord—brain cancer	8.35e-05	0.000657	CbGeAlD
Sunitinib—PRKAA1—cerebellum—brain cancer	8.35e-05	0.000657	CbGeAlD
Sunitinib—Nausea—Hydroxyurea—brain cancer	8.33e-05	0.000877	CcSEcCtD
Sunitinib—DAPK3—brain—brain cancer	8.32e-05	0.000655	CbGeAlD
Sunitinib—CSNK1E—central nervous system—brain cancer	8.31e-05	0.000654	CbGeAlD
Sunitinib—RPS6KB1—endocrine gland—brain cancer	8.3e-05	0.000653	CbGeAlD
Sunitinib—FLT1—midbrain—brain cancer	8.28e-05	0.000651	CbGeAlD
Sunitinib—PTK2B—cerebellum—brain cancer	8.26e-05	0.00065	CbGeAlD
Sunitinib—RET—endocrine gland—brain cancer	8.25e-05	0.000649	CbGeAlD
Sunitinib—FGR—endocrine gland—brain cancer	8.25e-05	0.000649	CbGeAlD
Sunitinib—CLK2—brain—brain cancer	8.24e-05	0.000649	CbGeAlD
Sunitinib—AXL—endocrine gland—brain cancer	8.22e-05	0.000647	CbGeAlD
Sunitinib—MAP4K2—brain—brain cancer	8.2e-05	0.000646	CbGeAlD
Sunitinib—RPS6KB1—head—brain cancer	8.2e-05	0.000645	CbGeAlD
Sunitinib—IRAK4—central nervous system—brain cancer	8.18e-05	0.000644	CbGeAlD
Sunitinib—EPHB6—midbrain—brain cancer	8.18e-05	0.000644	CbGeAlD
Sunitinib—FGR—head—brain cancer	8.15e-05	0.000641	CbGeAlD
Sunitinib—RET—head—brain cancer	8.15e-05	0.000641	CbGeAlD
Sunitinib—Asthenia—Carmustine—brain cancer	8.13e-05	0.000856	CcSEcCtD
Sunitinib—CSNK1E—cerebellum—brain cancer	8.12e-05	0.000639	CbGeAlD
Sunitinib—FGFR1—cerebellum—brain cancer	8.12e-05	0.000639	CbGeAlD
Sunitinib—AXL—head—brain cancer	8.12e-05	0.000639	CbGeAlD
Sunitinib—STK3—brain—brain cancer	8.09e-05	0.000637	CbGeAlD
Sunitinib—FLT1—spinal cord—brain cancer	8.07e-05	0.000635	CbGeAlD
Sunitinib—Hypersensitivity—Temozolomide—brain cancer	8.07e-05	0.00085	CcSEcCtD
Sunitinib—ULK3—central nervous system—brain cancer	8e-05	0.000629	CbGeAlD
Sunitinib—MAP2K2—central nervous system—brain cancer	8e-05	0.000629	CbGeAlD
Sunitinib—IRAK4—cerebellum—brain cancer	8e-05	0.000629	CbGeAlD
Sunitinib—ROCK1—brain—brain cancer	7.99e-05	0.000629	CbGeAlD
Sunitinib—EPHB6—spinal cord—brain cancer	7.98e-05	0.000628	CbGeAlD
Sunitinib—MAP3K2—central nervous system—brain cancer	7.94e-05	0.000625	CbGeAlD
Sunitinib—CSF1R—gonad—brain cancer	7.93e-05	0.000624	CbGeAlD
Sunitinib—KDR—pituitary gland—brain cancer	7.93e-05	0.000624	CbGeAlD
Sunitinib—MAP2K5—pituitary gland—brain cancer	7.93e-05	0.000624	CbGeAlD
Sunitinib—YES1—midbrain—brain cancer	7.91e-05	0.000622	CbGeAlD
Sunitinib—CYP3A7—endocrine gland—brain cancer	7.88e-05	0.00062	CbGeAlD
Sunitinib—Paraesthesia—Etoposide—brain cancer	7.87e-05	0.000829	CcSEcCtD
Sunitinib—Asthenia—Temozolomide—brain cancer	7.86e-05	0.000828	CcSEcCtD
Sunitinib—FGFR2—endocrine gland—brain cancer	7.84e-05	0.000617	CbGeAlD
Sunitinib—ULK3—cerebellum—brain cancer	7.82e-05	0.000615	CbGeAlD
Sunitinib—MAP2K2—cerebellum—brain cancer	7.82e-05	0.000615	CbGeAlD
Sunitinib—Dyspnoea—Etoposide—brain cancer	7.82e-05	0.000823	CcSEcCtD
Sunitinib—TAOK3—midbrain—brain cancer	7.8e-05	0.000614	CbGeAlD
Sunitinib—JAK2—endocrine gland—brain cancer	7.8e-05	0.000614	CbGeAlD
Sunitinib—DYRK1A—brain—brain cancer	7.79e-05	0.000613	CbGeAlD
Sunitinib—TBK1—central nervous system—brain cancer	7.78e-05	0.000612	CbGeAlD
Sunitinib—MAP3K2—cerebellum—brain cancer	7.76e-05	0.000611	CbGeAlD
Sunitinib—Diarrhoea—Carmustine—brain cancer	7.76e-05	0.000817	CcSEcCtD
Sunitinib—Pruritus—Temozolomide—brain cancer	7.75e-05	0.000816	CcSEcCtD
Sunitinib—FGFR2—head—brain cancer	7.74e-05	0.000609	CbGeAlD
Sunitinib—CSF1R—pituitary gland—brain cancer	7.74e-05	0.000609	CbGeAlD
Sunitinib—TYK2—central nervous system—brain cancer	7.73e-05	0.000608	CbGeAlD
Sunitinib—YES1—spinal cord—brain cancer	7.71e-05	0.000607	CbGeAlD
Sunitinib—JAK2—head—brain cancer	7.7e-05	0.000606	CbGeAlD
Sunitinib—FYN—endocrine gland—brain cancer	7.69e-05	0.000605	CbGeAlD
Sunitinib—MAP3K7—cerebellum—brain cancer	7.69e-05	0.000605	CbGeAlD
Sunitinib—KDR—medulla oblongata—brain cancer	7.65e-05	0.000602	CbGeAlD
Sunitinib—MAP2K5—medulla oblongata—brain cancer	7.65e-05	0.000602	CbGeAlD
Sunitinib—Decreased appetite—Etoposide—brain cancer	7.62e-05	0.000802	CcSEcCtD
Sunitinib—TAOK3—spinal cord—brain cancer	7.61e-05	0.000599	CbGeAlD
Sunitinib—MERTK—brain—brain cancer	7.61e-05	0.000599	CbGeAlD
Sunitinib—TBK1—cerebellum—brain cancer	7.6e-05	0.000598	CbGeAlD
Sunitinib—FYN—head—brain cancer	7.6e-05	0.000598	CbGeAlD
Sunitinib—Gastrointestinal disorder—Etoposide—brain cancer	7.57e-05	0.000797	CcSEcCtD
Sunitinib—PDGFRA—spinal cord—brain cancer	7.57e-05	0.000595	CbGeAlD
Sunitinib—Fatigue—Etoposide—brain cancer	7.56e-05	0.000796	CcSEcCtD
Sunitinib—TYK2—cerebellum—brain cancer	7.55e-05	0.000594	CbGeAlD
Sunitinib—MAP3K3—endocrine gland—brain cancer	7.52e-05	0.000592	CbGeAlD
Sunitinib—MAP4K5—endocrine gland—brain cancer	7.52e-05	0.000592	CbGeAlD
Sunitinib—Dizziness—Carmustine—brain cancer	7.5e-05	0.000789	CcSEcCtD
Sunitinib—Constipation—Etoposide—brain cancer	7.5e-05	0.000789	CcSEcCtD
Sunitinib—Pain—Etoposide—brain cancer	7.5e-05	0.000789	CcSEcCtD
Sunitinib—Diarrhoea—Temozolomide—brain cancer	7.5e-05	0.000789	CcSEcCtD
Sunitinib—RPS6KB1—central nervous system—brain cancer	7.48e-05	0.000589	CbGeAlD
Sunitinib—CSF1R—medulla oblongata—brain cancer	7.47e-05	0.000588	CbGeAlD
Sunitinib—MAP4K4—brain—brain cancer	7.47e-05	0.000588	CbGeAlD
Sunitinib—IRAK1—cerebellum—brain cancer	7.45e-05	0.000586	CbGeAlD
Sunitinib—FGR—central nervous system—brain cancer	7.44e-05	0.000585	CbGeAlD
Sunitinib—RET—central nervous system—brain cancer	7.44e-05	0.000585	CbGeAlD
Sunitinib—MAP3K3—head—brain cancer	7.42e-05	0.000584	CbGeAlD
Sunitinib—MAP4K5—head—brain cancer	7.42e-05	0.000584	CbGeAlD
Sunitinib—NUAK2—brain—brain cancer	7.42e-05	0.000584	CbGeAlD
Sunitinib—AXL—central nervous system—brain cancer	7.41e-05	0.000583	CbGeAlD
Sunitinib—MAP3K12—brain—brain cancer	7.36e-05	0.000579	CbGeAlD
Sunitinib—RPS6KB1—cerebellum—brain cancer	7.31e-05	0.000576	CbGeAlD
Sunitinib—RET—cerebellum—brain cancer	7.27e-05	0.000572	CbGeAlD
Sunitinib—FLT1—endocrine gland—brain cancer	7.27e-05	0.000572	CbGeAlD
Sunitinib—RPS6KA3—brain—brain cancer	7.26e-05	0.000571	CbGeAlD
Sunitinib—Dizziness—Temozolomide—brain cancer	7.24e-05	0.000763	CcSEcCtD
Sunitinib—AXL—cerebellum—brain cancer	7.24e-05	0.00057	CbGeAlD
Sunitinib—MAP2K1—brain—brain cancer	7.21e-05	0.000568	CbGeAlD
Sunitinib—Vomiting—Carmustine—brain cancer	7.21e-05	0.000759	CcSEcCtD
Sunitinib—KIT—gonad—brain cancer	7.21e-05	0.000567	CbGeAlD
Sunitinib—FLT1—head—brain cancer	7.18e-05	0.000565	CbGeAlD
Sunitinib—Gastrointestinal pain—Etoposide—brain cancer	7.17e-05	0.000755	CcSEcCtD
Sunitinib—Rash—Carmustine—brain cancer	7.15e-05	0.000753	CcSEcCtD
Sunitinib—Dermatitis—Carmustine—brain cancer	7.14e-05	0.000752	CcSEcCtD
Sunitinib—CSNK1A1—brain—brain cancer	7.12e-05	0.00056	CbGeAlD
Sunitinib—Headache—Carmustine—brain cancer	7.1e-05	0.000748	CcSEcCtD
Sunitinib—EPHB6—head—brain cancer	7.09e-05	0.000558	CbGeAlD
Sunitinib—CLK1—brain—brain cancer	7.07e-05	0.000557	CbGeAlD
Sunitinib—FGFR2—central nervous system—brain cancer	7.07e-05	0.000556	CbGeAlD
Sunitinib—PDGFRB—gonad—brain cancer	7.04e-05	0.000554	CbGeAlD
Sunitinib—JAK2—central nervous system—brain cancer	7.03e-05	0.000553	CbGeAlD
Sunitinib—KIT—pituitary gland—brain cancer	7.03e-05	0.000553	CbGeAlD
Sunitinib—MAP2K5—midbrain—brain cancer	7e-05	0.00055	CbGeAlD
Sunitinib—KDR—midbrain—brain cancer	7e-05	0.00055	CbGeAlD
Sunitinib—SLK—cerebellum—brain cancer	6.97e-05	0.000548	CbGeAlD
Sunitinib—Vomiting—Temozolomide—brain cancer	6.97e-05	0.000733	CcSEcCtD
Sunitinib—BMP2K—brain—brain cancer	6.94e-05	0.000546	CbGeAlD
Sunitinib—CAMK2G—brain—brain cancer	6.94e-05	0.000546	CbGeAlD
Sunitinib—YES1—endocrine gland—brain cancer	6.94e-05	0.000546	CbGeAlD
Sunitinib—FYN—central nervous system—brain cancer	6.93e-05	0.000546	CbGeAlD
Sunitinib—Abdominal pain—Etoposide—brain cancer	6.93e-05	0.00073	CcSEcCtD
Sunitinib—Body temperature increased—Etoposide—brain cancer	6.93e-05	0.00073	CcSEcCtD
Sunitinib—Rash—Temozolomide—brain cancer	6.91e-05	0.000727	CcSEcCtD
Sunitinib—FGFR2—cerebellum—brain cancer	6.91e-05	0.000543	CbGeAlD
Sunitinib—Dermatitis—Temozolomide—brain cancer	6.9e-05	0.000727	CcSEcCtD
Sunitinib—LRRK2—brain—brain cancer	6.88e-05	0.000542	CbGeAlD
Sunitinib—STK10—endocrine gland—brain cancer	6.88e-05	0.000541	CbGeAlD
Sunitinib—JAK2—cerebellum—brain cancer	6.87e-05	0.000541	CbGeAlD
Sunitinib—PDGFRB—pituitary gland—brain cancer	6.87e-05	0.00054	CbGeAlD
Sunitinib—Headache—Temozolomide—brain cancer	6.86e-05	0.000723	CcSEcCtD
Sunitinib—YES1—head—brain cancer	6.85e-05	0.000539	CbGeAlD
Sunitinib—TAOK3—endocrine gland—brain cancer	6.85e-05	0.000539	CbGeAlD
Sunitinib—CSF1R—midbrain—brain cancer	6.83e-05	0.000537	CbGeAlD
Sunitinib—MAP2K5—spinal cord—brain cancer	6.83e-05	0.000537	CbGeAlD
Sunitinib—KDR—spinal cord—brain cancer	6.83e-05	0.000537	CbGeAlD
Sunitinib—PDGFRA—endocrine gland—brain cancer	6.81e-05	0.000536	CbGeAlD
Sunitinib—STK10—head—brain cancer	6.79e-05	0.000535	CbGeAlD
Sunitinib—KIT—medulla oblongata—brain cancer	6.78e-05	0.000534	CbGeAlD
Sunitinib—PRKAA1—brain—brain cancer	6.78e-05	0.000534	CbGeAlD
Sunitinib—FYN—cerebellum—brain cancer	6.78e-05	0.000533	CbGeAlD
Sunitinib—MAP4K5—central nervous system—brain cancer	6.78e-05	0.000533	CbGeAlD
Sunitinib—MAP3K3—central nervous system—brain cancer	6.78e-05	0.000533	CbGeAlD
Sunitinib—TAOK3—head—brain cancer	6.77e-05	0.000532	CbGeAlD
Sunitinib—Nausea—Carmustine—brain cancer	6.73e-05	0.000709	CcSEcCtD
Sunitinib—PDGFRA—head—brain cancer	6.72e-05	0.000529	CbGeAlD
Sunitinib—PTK2B—brain—brain cancer	6.71e-05	0.000528	CbGeAlD
Sunitinib—FLT4—brain—brain cancer	6.69e-05	0.000526	CbGeAlD
Sunitinib—CSF1R—spinal cord—brain cancer	6.66e-05	0.000524	CbGeAlD
Sunitinib—PDGFRB—medulla oblongata—brain cancer	6.63e-05	0.000521	CbGeAlD
Sunitinib—MAP4K5—cerebellum—brain cancer	6.62e-05	0.000521	CbGeAlD
Sunitinib—MAP3K3—cerebellum—brain cancer	6.62e-05	0.000521	CbGeAlD
Sunitinib—FGFR1—brain—brain cancer	6.6e-05	0.000519	CbGeAlD
Sunitinib—CSNK1E—brain—brain cancer	6.6e-05	0.000519	CbGeAlD
Sunitinib—FLT1—central nervous system—brain cancer	6.55e-05	0.000515	CbGeAlD
Sunitinib—Nausea—Temozolomide—brain cancer	6.51e-05	0.000685	CcSEcCtD
Sunitinib—IRAK4—brain—brain cancer	6.5e-05	0.000511	CbGeAlD
Sunitinib—EPHB6—central nervous system—brain cancer	6.47e-05	0.000509	CbGeAlD
Sunitinib—Hypersensitivity—Etoposide—brain cancer	6.46e-05	0.00068	CcSEcCtD
Sunitinib—FLT1—cerebellum—brain cancer	6.4e-05	0.000504	CbGeAlD
Sunitinib—ULK3—brain—brain cancer	6.35e-05	0.0005	CbGeAlD
Sunitinib—MAP2K2—brain—brain cancer	6.35e-05	0.0005	CbGeAlD
Sunitinib—EPHB6—cerebellum—brain cancer	6.33e-05	0.000498	CbGeAlD
Sunitinib—MAP3K2—brain—brain cancer	6.31e-05	0.000496	CbGeAlD
Sunitinib—Asthenia—Etoposide—brain cancer	6.29e-05	0.000662	CcSEcCtD
Sunitinib—YES1—central nervous system—brain cancer	6.26e-05	0.000492	CbGeAlD
Sunitinib—MAP3K7—brain—brain cancer	6.25e-05	0.000492	CbGeAlD
Sunitinib—Pruritus—Etoposide—brain cancer	6.2e-05	0.000653	CcSEcCtD
Sunitinib—STK10—central nervous system—brain cancer	6.2e-05	0.000488	CbGeAlD
Sunitinib—KIT—midbrain—brain cancer	6.2e-05	0.000488	CbGeAlD
Sunitinib—TAOK3—central nervous system—brain cancer	6.18e-05	0.000486	CbGeAlD
Sunitinib—TBK1—brain—brain cancer	6.18e-05	0.000486	CbGeAlD
Sunitinib—KDR—endocrine gland—brain cancer	6.14e-05	0.000483	CbGeAlD
Sunitinib—MAP2K5—endocrine gland—brain cancer	6.14e-05	0.000483	CbGeAlD
Sunitinib—PDGFRA—central nervous system—brain cancer	6.14e-05	0.000483	CbGeAlD
Sunitinib—TYK2—brain—brain cancer	6.13e-05	0.000483	CbGeAlD
Sunitinib—YES1—cerebellum—brain cancer	6.12e-05	0.000481	CbGeAlD
Sunitinib—KDR—head—brain cancer	6.07e-05	0.000477	CbGeAlD
Sunitinib—MAP2K5—head—brain cancer	6.07e-05	0.000477	CbGeAlD
Sunitinib—STK10—cerebellum—brain cancer	6.06e-05	0.000477	CbGeAlD
Sunitinib—PDGFRB—midbrain—brain cancer	6.06e-05	0.000476	CbGeAlD
Sunitinib—IRAK1—brain—brain cancer	6.05e-05	0.000476	CbGeAlD
Sunitinib—KIT—spinal cord—brain cancer	6.05e-05	0.000476	CbGeAlD
Sunitinib—TAOK3—cerebellum—brain cancer	6.04e-05	0.000475	CbGeAlD
Sunitinib—PDGFRA—cerebellum—brain cancer	6e-05	0.000472	CbGeAlD
Sunitinib—Diarrhoea—Etoposide—brain cancer	6e-05	0.000632	CcSEcCtD
Sunitinib—CSF1R—endocrine gland—brain cancer	6e-05	0.000472	CbGeAlD
Sunitinib—RPS6KB1—brain—brain cancer	5.94e-05	0.000467	CbGeAlD
Sunitinib—CSF1R—head—brain cancer	5.92e-05	0.000466	CbGeAlD
Sunitinib—PDGFRB—spinal cord—brain cancer	5.91e-05	0.000465	CbGeAlD
Sunitinib—FGR—brain—brain cancer	5.9e-05	0.000465	CbGeAlD
Sunitinib—RET—brain—brain cancer	5.9e-05	0.000465	CbGeAlD
Sunitinib—AXL—brain—brain cancer	5.88e-05	0.000463	CbGeAlD
Sunitinib—Dizziness—Etoposide—brain cancer	5.8e-05	0.00061	CcSEcCtD
Sunitinib—SLK—brain—brain cancer	5.66e-05	0.000445	CbGeAlD
Sunitinib—FGFR2—brain—brain cancer	5.61e-05	0.000441	CbGeAlD
Sunitinib—JAK2—brain—brain cancer	5.58e-05	0.000439	CbGeAlD
Sunitinib—Vomiting—Etoposide—brain cancer	5.57e-05	0.000587	CcSEcCtD
Sunitinib—MAP2K5—central nervous system—brain cancer	5.54e-05	0.000436	CbGeAlD
Sunitinib—KDR—central nervous system—brain cancer	5.54e-05	0.000436	CbGeAlD
Sunitinib—Rash—Etoposide—brain cancer	5.53e-05	0.000582	CcSEcCtD
Sunitinib—Dermatitis—Etoposide—brain cancer	5.52e-05	0.000581	CcSEcCtD
Sunitinib—FYN—brain—brain cancer	5.5e-05	0.000433	CbGeAlD
Sunitinib—Headache—Etoposide—brain cancer	5.49e-05	0.000578	CcSEcCtD
Sunitinib—KIT—endocrine gland—brain cancer	5.45e-05	0.000428	CbGeAlD
Sunitinib—KDR—cerebellum—brain cancer	5.41e-05	0.000426	CbGeAlD
Sunitinib—MAP2K5—cerebellum—brain cancer	5.41e-05	0.000426	CbGeAlD
Sunitinib—CSF1R—central nervous system—brain cancer	5.4e-05	0.000425	CbGeAlD
Sunitinib—MAP4K5—brain—brain cancer	5.38e-05	0.000423	CbGeAlD
Sunitinib—MAP3K3—brain—brain cancer	5.38e-05	0.000423	CbGeAlD
Sunitinib—KIT—head—brain cancer	5.38e-05	0.000423	CbGeAlD
Sunitinib—KCNH2—telencephalon—brain cancer	5.33e-05	0.000419	CbGeAlD
Sunitinib—PDGFRB—endocrine gland—brain cancer	5.32e-05	0.000418	CbGeAlD
Sunitinib—CSF1R—cerebellum—brain cancer	5.28e-05	0.000416	CbGeAlD
Sunitinib—PDGFRB—head—brain cancer	5.25e-05	0.000413	CbGeAlD
Sunitinib—Nausea—Etoposide—brain cancer	5.21e-05	0.000548	CcSEcCtD
Sunitinib—FLT1—brain—brain cancer	5.2e-05	0.000409	CbGeAlD
Sunitinib—EPHB6—brain—brain cancer	5.14e-05	0.000404	CbGeAlD
Sunitinib—YES1—brain—brain cancer	4.97e-05	0.000391	CbGeAlD
Sunitinib—STK10—brain—brain cancer	4.92e-05	0.000387	CbGeAlD
Sunitinib—KIT—central nervous system—brain cancer	4.91e-05	0.000386	CbGeAlD
Sunitinib—TAOK3—brain—brain cancer	4.9e-05	0.000386	CbGeAlD
Sunitinib—PDGFRA—brain—brain cancer	4.87e-05	0.000383	CbGeAlD
Sunitinib—ABCB1—blood vessel—brain cancer	4.82e-05	0.000379	CbGeAlD
Sunitinib—KIT—cerebellum—brain cancer	4.8e-05	0.000377	CbGeAlD
Sunitinib—PDGFRB—central nervous system—brain cancer	4.79e-05	0.000377	CbGeAlD
Sunitinib—ABCG2—telencephalon—brain cancer	4.74e-05	0.000373	CbGeAlD
Sunitinib—PDGFRB—cerebellum—brain cancer	4.68e-05	0.000369	CbGeAlD
Sunitinib—KDR—brain—brain cancer	4.4e-05	0.000346	CbGeAlD
Sunitinib—MAP2K5—brain—brain cancer	4.4e-05	0.000346	CbGeAlD
Sunitinib—KCNH2—pituitary gland—brain cancer	4.34e-05	0.000341	CbGeAlD
Sunitinib—CSF1R—brain—brain cancer	4.29e-05	0.000338	CbGeAlD
Sunitinib—ABCC4—endocrine gland—brain cancer	4.23e-05	0.000333	CbGeAlD
Sunitinib—KCNH2—medulla oblongata—brain cancer	4.19e-05	0.000329	CbGeAlD
Sunitinib—ABCC4—head—brain cancer	4.18e-05	0.000329	CbGeAlD
Sunitinib—ABCC2—endocrine gland—brain cancer	4.1e-05	0.000323	CbGeAlD
Sunitinib—KIT—brain—brain cancer	3.9e-05	0.000307	CbGeAlD
Sunitinib—ABCG2—pituitary gland—brain cancer	3.86e-05	0.000304	CbGeAlD
Sunitinib—KCNH2—midbrain—brain cancer	3.83e-05	0.000301	CbGeAlD
Sunitinib—ABCC4—central nervous system—brain cancer	3.82e-05	0.0003	CbGeAlD
Sunitinib—PDGFRB—brain—brain cancer	3.8e-05	0.000299	CbGeAlD
Sunitinib—KCNH2—spinal cord—brain cancer	3.73e-05	0.000294	CbGeAlD
Sunitinib—ABCG2—medulla oblongata—brain cancer	3.72e-05	0.000293	CbGeAlD
Sunitinib—ABCG2—midbrain—brain cancer	3.4e-05	0.000268	CbGeAlD
Sunitinib—KCNH2—endocrine gland—brain cancer	3.36e-05	0.000264	CbGeAlD
Sunitinib—ABCG2—spinal cord—brain cancer	3.32e-05	0.000261	CbGeAlD
Sunitinib—KCNH2—head—brain cancer	3.32e-05	0.000261	CbGeAlD
Sunitinib—ABCC4—brain—brain cancer	3.03e-05	0.000238	CbGeAlD
Sunitinib—KCNH2—central nervous system—brain cancer	3.03e-05	0.000238	CbGeAlD
Sunitinib—KCNH2—cerebellum—brain cancer	2.96e-05	0.000233	CbGeAlD
Sunitinib—CYP3A5—endocrine gland—brain cancer	2.77e-05	0.000218	CbGeAlD
Sunitinib—ABCG2—cerebellum—brain cancer	2.63e-05	0.000207	CbGeAlD
Sunitinib—KCNH2—brain—brain cancer	2.4e-05	0.000189	CbGeAlD
Sunitinib—ABCB1—telencephalon—brain cancer	2.34e-05	0.000184	CbGeAlD
Sunitinib—ABCG2—brain—brain cancer	2.14e-05	0.000168	CbGeAlD
Sunitinib—CYP3A4—endocrine gland—brain cancer	2.08e-05	0.000164	CbGeAlD
Sunitinib—ABCB1—gonad—brain cancer	1.95e-05	0.000153	CbGeAlD
Sunitinib—ABCB1—pituitary gland—brain cancer	1.9e-05	0.00015	CbGeAlD
Sunitinib—CYP3A4—central nervous system—brain cancer	1.88e-05	0.000148	CbGeAlD
Sunitinib—ABCB1—medulla oblongata—brain cancer	1.84e-05	0.000144	CbGeAlD
Sunitinib—ABCB1—midbrain—brain cancer	1.68e-05	0.000132	CbGeAlD
Sunitinib—ABCB1—spinal cord—brain cancer	1.64e-05	0.000129	CbGeAlD
Sunitinib—ABCB1—endocrine gland—brain cancer	1.47e-05	0.000116	CbGeAlD
Sunitinib—ABCB1—head—brain cancer	1.46e-05	0.000115	CbGeAlD
Sunitinib—ABCB1—central nervous system—brain cancer	1.33e-05	0.000105	CbGeAlD
Sunitinib—ABCB1—cerebellum—brain cancer	1.3e-05	0.000102	CbGeAlD
Sunitinib—ABCB1—brain—brain cancer	1.05e-05	8.3e-05	CbGeAlD
Sunitinib—IRAK1—Immune System—EGFR—brain cancer	1.3e-06	7.96e-06	CbGpPWpGaD
Sunitinib—RPS6KA1—Signaling Pathways—TP53—brain cancer	1.3e-06	7.95e-06	CbGpPWpGaD
Sunitinib—KDR—Signaling Pathways—CTNNB1—brain cancer	1.29e-06	7.89e-06	CbGpPWpGaD
Sunitinib—FLT1—Signaling Pathways—TP53—brain cancer	1.29e-06	7.89e-06	CbGpPWpGaD
Sunitinib—YES1—Signaling Pathways—RELA—brain cancer	1.29e-06	7.88e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—PIK3CG—brain cancer	1.29e-06	7.87e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—APC—brain cancer	1.29e-06	7.87e-06	CbGpPWpGaD
Sunitinib—TYK2—Disease—STAT3—brain cancer	1.28e-06	7.85e-06	CbGpPWpGaD
Sunitinib—YES1—Signaling Pathways—ERBB2—brain cancer	1.28e-06	7.83e-06	CbGpPWpGaD
Sunitinib—FGFR1—Immune System—STAT3—brain cancer	1.28e-06	7.83e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Immune System—STAT3—brain cancer	1.28e-06	7.81e-06	CbGpPWpGaD
Sunitinib—JAK2—Disease—ERBB2—brain cancer	1.28e-06	7.8e-06	CbGpPWpGaD
Sunitinib—PRKAA1—Signaling Pathways—MYC—brain cancer	1.27e-06	7.78e-06	CbGpPWpGaD
Sunitinib—FYN—Immune System—CTNNB1—brain cancer	1.27e-06	7.78e-06	CbGpPWpGaD
Sunitinib—FGFR2—Disease—STAT3—brain cancer	1.27e-06	7.75e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Immune System—CTNNB1—brain cancer	1.27e-06	7.74e-06	CbGpPWpGaD
Sunitinib—TYK2—Immune System—EGFR—brain cancer	1.26e-06	7.73e-06	CbGpPWpGaD
Sunitinib—RPS6KA3—Signaling Pathways—MYC—brain cancer	1.26e-06	7.71e-06	CbGpPWpGaD
Sunitinib—PTK2B—Signaling Pathways—VEGFA—brain cancer	1.26e-06	7.68e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—PIK3CG—brain cancer	1.26e-06	7.68e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—APC—brain cancer	1.26e-06	7.68e-06	CbGpPWpGaD
Sunitinib—JAK2—Immune System—IL2—brain cancer	1.25e-06	7.66e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Disease—CTNNB1—brain cancer	1.25e-06	7.64e-06	CbGpPWpGaD
Sunitinib—FGFR2—Immune System—EGFR—brain cancer	1.25e-06	7.63e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—BSG—brain cancer	1.25e-06	7.63e-06	CbGpPWpGaD
Sunitinib—KIT—Disease—STAT3—brain cancer	1.25e-06	7.62e-06	CbGpPWpGaD
Sunitinib—PRKAA1—Signaling Pathways—EGFR—brain cancer	1.25e-06	7.61e-06	CbGpPWpGaD
Sunitinib—PTK2B—Signaling Pathways—STAT3—brain cancer	1.24e-06	7.61e-06	CbGpPWpGaD
Sunitinib—RPS6KA3—Signaling Pathways—EGFR—brain cancer	1.23e-06	7.54e-06	CbGpPWpGaD
Sunitinib—KIT—Immune System—EGFR—brain cancer	1.23e-06	7.5e-06	CbGpPWpGaD
Sunitinib—MAP3K7—Immune System—EGFR—brain cancer	1.23e-06	7.5e-06	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—RELA—brain cancer	1.22e-06	7.47e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Disease—CTNNB1—brain cancer	1.22e-06	7.45e-06	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—ERBB2—brain cancer	1.21e-06	7.43e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—APC—brain cancer	1.21e-06	7.4e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—PIK3CG—brain cancer	1.21e-06	7.4e-06	CbGpPWpGaD
Sunitinib—ROCK1—Signaling Pathways—VEGFA—brain cancer	1.21e-06	7.4e-06	CbGpPWpGaD
Sunitinib—JAK2—Immune System—CTNNB1—brain cancer	1.21e-06	7.39e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—PIK3CG—brain cancer	1.2e-06	7.36e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—APC—brain cancer	1.2e-06	7.36e-06	CbGpPWpGaD
Sunitinib—NTRK1—Signaling Pathways—VEGFA—brain cancer	1.2e-06	7.35e-06	CbGpPWpGaD
Sunitinib—ROCK1—Signaling Pathways—STAT3—brain cancer	1.2e-06	7.33e-06	CbGpPWpGaD
Sunitinib—TYK2—Disease—MYC—brain cancer	1.19e-06	7.3e-06	CbGpPWpGaD
Sunitinib—NTRK1—Signaling Pathways—STAT3—brain cancer	1.19e-06	7.28e-06	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—RELA—brain cancer	1.19e-06	7.26e-06	CbGpPWpGaD
Sunitinib—FGFR1—Disease—STAT3—brain cancer	1.18e-06	7.23e-06	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—ERBB2—brain cancer	1.18e-06	7.21e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Disease—STAT3—brain cancer	1.18e-06	7.21e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Immune System—STAT3—brain cancer	1.18e-06	7.21e-06	CbGpPWpGaD
Sunitinib—FGFR2—Disease—MYC—brain cancer	1.18e-06	7.21e-06	CbGpPWpGaD
Sunitinib—FYN—Disease—CTNNB1—brain cancer	1.17e-06	7.18e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling by GPCR—EGFR—brain cancer	1.17e-06	7.17e-06	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—RELA—brain cancer	1.17e-06	7.17e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Disease—CTNNB1—brain cancer	1.17e-06	7.14e-06	CbGpPWpGaD
Sunitinib—ABCG2—Metabolism—PIK3CG—brain cancer	1.17e-06	7.14e-06	CbGpPWpGaD
Sunitinib—TYK2—Disease—EGFR—brain cancer	1.17e-06	7.14e-06	CbGpPWpGaD
Sunitinib—RPS6KB1—Signaling Pathways—VEGFA—brain cancer	1.17e-06	7.13e-06	CbGpPWpGaD
Sunitinib—MAP2K5—Signaling Pathways—VEGFA—brain cancer	1.17e-06	7.13e-06	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—ERBB2—brain cancer	1.16e-06	7.12e-06	CbGpPWpGaD
Sunitinib—FGFR1—Immune System—EGFR—brain cancer	1.16e-06	7.12e-06	CbGpPWpGaD
Sunitinib—YES1—Signaling Pathways—IL2—brain cancer	1.16e-06	7.1e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Immune System—EGFR—brain cancer	1.16e-06	7.1e-06	CbGpPWpGaD
Sunitinib—CYP3A7—Metabolism—PIK3CG—brain cancer	1.16e-06	7.08e-06	CbGpPWpGaD
Sunitinib—KIT—Disease—MYC—brain cancer	1.16e-06	7.08e-06	CbGpPWpGaD
Sunitinib—PTK2B—Signaling Pathways—MYC—brain cancer	1.16e-06	7.07e-06	CbGpPWpGaD
Sunitinib—MAP2K5—Signaling Pathways—STAT3—brain cancer	1.15e-06	7.06e-06	CbGpPWpGaD
Sunitinib—RPS6KB1—Signaling Pathways—STAT3—brain cancer	1.15e-06	7.06e-06	CbGpPWpGaD
Sunitinib—FGFR2—Disease—EGFR—brain cancer	1.15e-06	7.05e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—PIK3CG—brain cancer	1.15e-06	7.04e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—APC—brain cancer	1.15e-06	7.04e-06	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—RELA—brain cancer	1.15e-06	7.04e-06	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—RELA—brain cancer	1.15e-06	7.04e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Immune System—STAT3—brain cancer	1.15e-06	7.03e-06	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—ERBB2—brain cancer	1.14e-06	6.99e-06	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—ERBB2—brain cancer	1.14e-06	6.99e-06	CbGpPWpGaD
Sunitinib—KDR—Signaling Pathways—VEGFA—brain cancer	1.14e-06	6.95e-06	CbGpPWpGaD
Sunitinib—KIT—Disease—EGFR—brain cancer	1.13e-06	6.92e-06	CbGpPWpGaD
Sunitinib—YES1—Signaling Pathways—CCND1—brain cancer	1.13e-06	6.92e-06	CbGpPWpGaD
Sunitinib—PTK2B—Signaling Pathways—EGFR—brain cancer	1.13e-06	6.91e-06	CbGpPWpGaD
Sunitinib—KDR—Signaling Pathways—STAT3—brain cancer	1.12e-06	6.88e-06	CbGpPWpGaD
Sunitinib—YES1—Signaling Pathways—CTNNB1—brain cancer	1.12e-06	6.85e-06	CbGpPWpGaD
Sunitinib—JAK2—Disease—CTNNB1—brain cancer	1.12e-06	6.83e-06	CbGpPWpGaD
Sunitinib—CSNK1E—Signaling Pathways—TP53—brain cancer	1.11e-06	6.81e-06	CbGpPWpGaD
Sunitinib—ROCK1—Signaling Pathways—MYC—brain cancer	1.11e-06	6.81e-06	CbGpPWpGaD
Sunitinib—FYN—Immune System—STAT3—brain cancer	1.11e-06	6.78e-06	CbGpPWpGaD
Sunitinib—NTRK1—Signaling Pathways—MYC—brain cancer	1.11e-06	6.76e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Immune System—STAT3—brain cancer	1.1e-06	6.74e-06	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—IL2—brain cancer	1.1e-06	6.73e-06	CbGpPWpGaD
Sunitinib—FGFR1—Disease—MYC—brain cancer	1.1e-06	6.72e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling by GPCR—EGFR—brain cancer	1.1e-06	6.71e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Disease—MYC—brain cancer	1.1e-06	6.7e-06	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—RELA—brain cancer	1.09e-06	6.68e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—RELA—brain cancer	1.09e-06	6.66e-06	CbGpPWpGaD
Sunitinib—ROCK1—Signaling Pathways—EGFR—brain cancer	1.09e-06	6.66e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Disease—STAT3—brain cancer	1.09e-06	6.66e-06	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—ERBB2—brain cancer	1.09e-06	6.64e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—ERBB2—brain cancer	1.08e-06	6.62e-06	CbGpPWpGaD
Sunitinib—NTRK1—Signaling Pathways—EGFR—brain cancer	1.08e-06	6.62e-06	CbGpPWpGaD
Sunitinib—FGFR1—Disease—EGFR—brain cancer	1.07e-06	6.57e-06	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—CCND1—brain cancer	1.07e-06	6.56e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—IDH1—brain cancer	1.07e-06	6.56e-06	CbGpPWpGaD
Sunitinib—RPS6KB1—Signaling Pathways—MYC—brain cancer	1.07e-06	6.56e-06	CbGpPWpGaD
Sunitinib—MAP2K5—Signaling Pathways—MYC—brain cancer	1.07e-06	6.56e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Disease—EGFR—brain cancer	1.07e-06	6.55e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Immune System—EGFR—brain cancer	1.07e-06	6.55e-06	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—IL2—brain cancer	1.07e-06	6.53e-06	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—CTNNB1—brain cancer	1.06e-06	6.5e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Disease—STAT3—brain cancer	1.06e-06	6.49e-06	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—IL2—brain cancer	1.06e-06	6.45e-06	CbGpPWpGaD
Sunitinib—JAK2—Immune System—STAT3—brain cancer	1.05e-06	6.45e-06	CbGpPWpGaD
Sunitinib—RPS6KB1—Signaling Pathways—EGFR—brain cancer	1.05e-06	6.41e-06	CbGpPWpGaD
Sunitinib—MAP2K5—Signaling Pathways—EGFR—brain cancer	1.05e-06	6.41e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling by GPCR—EGFR—brain cancer	1.05e-06	6.41e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Immune System—EGFR—brain cancer	1.05e-06	6.39e-06	CbGpPWpGaD
Sunitinib—PRKAA1—Signaling Pathways—TP53—brain cancer	1.05e-06	6.39e-06	CbGpPWpGaD
Sunitinib—KDR—Signaling Pathways—MYC—brain cancer	1.05e-06	6.39e-06	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—CCND1—brain cancer	1.04e-06	6.37e-06	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—IL2—brain cancer	1.04e-06	6.34e-06	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—IL2—brain cancer	1.04e-06	6.34e-06	CbGpPWpGaD
Sunitinib—RPS6KA3—Signaling Pathways—TP53—brain cancer	1.04e-06	6.33e-06	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—CTNNB1—brain cancer	1.03e-06	6.31e-06	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—CCND1—brain cancer	1.03e-06	6.29e-06	CbGpPWpGaD
Sunitinib—FYN—Disease—STAT3—brain cancer	1.02e-06	6.26e-06	CbGpPWpGaD
Sunitinib—KDR—Signaling Pathways—EGFR—brain cancer	1.02e-06	6.25e-06	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—CTNNB1—brain cancer	1.02e-06	6.23e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Disease—STAT3—brain cancer	1.02e-06	6.23e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Disease—MYC—brain cancer	1.01e-06	6.18e-06	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—CCND1—brain cancer	1.01e-06	6.18e-06	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—CCND1—brain cancer	1.01e-06	6.18e-06	CbGpPWpGaD
Sunitinib—FYN—Immune System—EGFR—brain cancer	1.01e-06	6.16e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—RELA—brain cancer	1.01e-06	6.15e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Immune System—EGFR—brain cancer	1e-06	6.13e-06	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—CTNNB1—brain cancer	1e-06	6.12e-06	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—CTNNB1—brain cancer	1e-06	6.12e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—ERBB2—brain cancer	9.99e-07	6.11e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Disease—EGFR—brain cancer	9.89e-07	6.05e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Disease—MYC—brain cancer	9.87e-07	6.04e-06	CbGpPWpGaD
Sunitinib—YES1—Signaling Pathways—VEGFA—brain cancer	9.86e-07	6.03e-06	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—IL2—brain cancer	9.84e-07	6.01e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—RELA—brain cancer	9.82e-07	6e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—IL2—brain cancer	9.81e-07	6e-06	CbGpPWpGaD
Sunitinib—YES1—Signaling Pathways—STAT3—brain cancer	9.77e-07	5.97e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—ERBB2—brain cancer	9.75e-07	5.96e-06	CbGpPWpGaD
Sunitinib—JAK2—Disease—STAT3—brain cancer	9.73e-07	5.95e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Disease—EGFR—brain cancer	9.65e-07	5.9e-06	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—CCND1—brain cancer	9.59e-07	5.86e-06	CbGpPWpGaD
Sunitinib—JAK2—Immune System—EGFR—brain cancer	9.58e-07	5.86e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—CCND1—brain cancer	9.57e-07	5.85e-06	CbGpPWpGaD
Sunitinib—FYN—Disease—MYC—brain cancer	9.51e-07	5.82e-06	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—CTNNB1—brain cancer	9.5e-07	5.81e-06	CbGpPWpGaD
Sunitinib—PTK2B—Signaling Pathways—TP53—brain cancer	9.49e-07	5.8e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—CTNNB1—brain cancer	9.47e-07	5.79e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Disease—MYC—brain cancer	9.46e-07	5.79e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—RELA—brain cancer	9.46e-07	5.78e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—RELA—brain cancer	9.41e-07	5.75e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—ERBB2—brain cancer	9.4e-07	5.75e-06	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—VEGFA—brain cancer	9.36e-07	5.72e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—ERBB2—brain cancer	9.35e-07	5.72e-06	CbGpPWpGaD
Sunitinib—FYN—Disease—EGFR—brain cancer	9.31e-07	5.69e-06	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—STAT3—brain cancer	9.26e-07	5.66e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Disease—EGFR—brain cancer	9.26e-07	5.66e-06	CbGpPWpGaD
Sunitinib—ROCK1—Signaling Pathways—TP53—brain cancer	9.14e-07	5.59e-06	CbGpPWpGaD
Sunitinib—NTRK1—Signaling Pathways—TP53—brain cancer	9.08e-07	5.55e-06	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—VEGFA—brain cancer	9.08e-07	5.55e-06	CbGpPWpGaD
Sunitinib—YES1—Signaling Pathways—MYC—brain cancer	9.08e-07	5.55e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—IL2—brain cancer	9.06e-07	5.54e-06	CbGpPWpGaD
Sunitinib—JAK2—Disease—MYC—brain cancer	9.04e-07	5.53e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—RELA—brain cancer	8.99e-07	5.5e-06	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—STAT3—brain cancer	8.99e-07	5.5e-06	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—VEGFA—brain cancer	8.97e-07	5.48e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—ERBB2—brain cancer	8.94e-07	5.46e-06	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—STAT3—brain cancer	8.88e-07	5.43e-06	CbGpPWpGaD
Sunitinib—YES1—Signaling Pathways—EGFR—brain cancer	8.88e-07	5.43e-06	CbGpPWpGaD
Sunitinib—JAK2—Disease—EGFR—brain cancer	8.85e-07	5.41e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—IL2—brain cancer	8.84e-07	5.4e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—CCND1—brain cancer	8.83e-07	5.4e-06	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—VEGFA—brain cancer	8.81e-07	5.39e-06	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—VEGFA—brain cancer	8.81e-07	5.39e-06	CbGpPWpGaD
Sunitinib—RPS6KB1—Signaling Pathways—TP53—brain cancer	8.81e-07	5.39e-06	CbGpPWpGaD
Sunitinib—MAP2K5—Signaling Pathways—TP53—brain cancer	8.81e-07	5.39e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—CTNNB1—brain cancer	8.74e-07	5.35e-06	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—STAT3—brain cancer	8.72e-07	5.33e-06	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—STAT3—brain cancer	8.72e-07	5.33e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—CCND1—brain cancer	8.62e-07	5.27e-06	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—MYC—brain cancer	8.61e-07	5.26e-06	CbGpPWpGaD
Sunitinib—KDR—Signaling Pathways—TP53—brain cancer	8.58e-07	5.25e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—CTNNB1—brain cancer	8.53e-07	5.22e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—IL2—brain cancer	8.52e-07	5.21e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—ENO2—brain cancer	8.48e-07	5.19e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—IL2—brain cancer	8.47e-07	5.18e-06	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—EGFR—brain cancer	8.42e-07	5.15e-06	CbGpPWpGaD
Sunitinib—CYP3A5—Metabolism—PIK3CG—brain cancer	8.37e-07	5.12e-06	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—VEGFA—brain cancer	8.36e-07	5.11e-06	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—MYC—brain cancer	8.36e-07	5.11e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—VEGFA—brain cancer	8.34e-07	5.1e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—CCND1—brain cancer	8.31e-07	5.08e-06	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—STAT3—brain cancer	8.28e-07	5.06e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—CCND1—brain cancer	8.26e-07	5.05e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—STAT3—brain cancer	8.26e-07	5.05e-06	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—MYC—brain cancer	8.25e-07	5.05e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—CTNNB1—brain cancer	8.23e-07	5.03e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—CTNNB1—brain cancer	8.18e-07	5e-06	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—EGFR—brain cancer	8.17e-07	5e-06	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—MYC—brain cancer	8.11e-07	4.96e-06	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—MYC—brain cancer	8.11e-07	4.96e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—IL2—brain cancer	8.1e-07	4.95e-06	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—EGFR—brain cancer	8.07e-07	4.94e-06	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—EGFR—brain cancer	7.93e-07	4.85e-06	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—EGFR—brain cancer	7.93e-07	4.85e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—CCND1—brain cancer	7.9e-07	4.83e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—CTNNB1—brain cancer	7.82e-07	4.78e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—VEGFA—brain cancer	7.7e-07	4.71e-06	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—MYC—brain cancer	7.69e-07	4.7e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—MYC—brain cancer	7.67e-07	4.69e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—STAT3—brain cancer	7.62e-07	4.66e-06	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—EGFR—brain cancer	7.52e-07	4.6e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—VEGFA—brain cancer	7.51e-07	4.59e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—EGFR—brain cancer	7.5e-07	4.59e-06	CbGpPWpGaD
Sunitinib—YES1—Signaling Pathways—TP53—brain cancer	7.45e-07	4.56e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—STAT3—brain cancer	7.44e-07	4.55e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—VEGFA—brain cancer	7.24e-07	4.43e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—VEGFA—brain cancer	7.2e-07	4.4e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—STAT3—brain cancer	7.17e-07	4.38e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—STAT3—brain cancer	7.13e-07	4.36e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—MYC—brain cancer	7.08e-07	4.33e-06	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—TP53—brain cancer	7.07e-07	4.32e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—EGFR—brain cancer	6.93e-07	4.24e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—MYC—brain cancer	6.91e-07	4.23e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—VEGFA—brain cancer	6.88e-07	4.21e-06	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—TP53—brain cancer	6.86e-07	4.2e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—STAT3—brain cancer	6.82e-07	4.17e-06	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—TP53—brain cancer	6.78e-07	4.14e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—EGFR—brain cancer	6.76e-07	4.13e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—MYC—brain cancer	6.66e-07	4.07e-06	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—TP53—brain cancer	6.66e-07	4.07e-06	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—TP53—brain cancer	6.66e-07	4.07e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—MYC—brain cancer	6.63e-07	4.05e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—EGFR—brain cancer	6.52e-07	3.98e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—EGFR—brain cancer	6.48e-07	3.96e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—MYC—brain cancer	6.33e-07	3.87e-06	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—TP53—brain cancer	6.32e-07	3.86e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—PIK3CG—brain cancer	6.31e-07	3.86e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—TP53—brain cancer	6.3e-07	3.85e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—EGFR—brain cancer	6.19e-07	3.79e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—TP53—brain cancer	5.82e-07	3.56e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—TP53—brain cancer	5.68e-07	3.47e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—TP53—brain cancer	5.47e-07	3.35e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—TP53—brain cancer	5.44e-07	3.33e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—TP53—brain cancer	5.2e-07	3.18e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—PIK3CG—brain cancer	3.89e-07	2.38e-06	CbGpPWpGaD
